Gene: CYP26B1
Official Full Name: cytochrome P450 family 26 subfamily B member 1provided by HGNC
Gene Summary: This gene encodes a member of the cytochrome P450 superfamily. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein is localized to the endoplasmic reticulum, and functions as a critical regulator of all-trans retinoic acid levels by the specific inactivation of all-trans retinoic acid to hydroxylated forms. Mutations in this gene are associated with radiohumeral fusions and other skeletal and craniofacial anomalies, and increased levels of the encoded protein are associated with atherosclerotic lesions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01472 | CYP26B1 Knockout cell line(KYSE-30) | Human | CYP26B1 | 1:2~1:4 | Negative | Online Inquiry |
KO18435 | CYP26B1 Knockout cell line (HeLa) | Human | CYP26B1 | 1:3~1:6 | Negative | Online Inquiry |
KO18436 | CYP26B1 Knockout cell line (HCT 116) | Human | CYP26B1 | 1:2~1:4 | Negative | Online Inquiry |
KO18437 | CYP26B1 Knockout cell line (HEK293) | Human | CYP26B1 | 1:3~1:6 | Negative | Online Inquiry |
KO18438 | CYP26B1 Knockout cell line (A549) | Human | CYP26B1 | 1:3~1:4 | Negative | Online Inquiry |
CYP26B1 Gene Knockout Cell Lines are genetically engineered cell models designed to facilitate the study of the cytochrome P450 26B1 enzyme, which plays a critical role in the metabolism of retinoic acid. This enzyme is essential for maintaining proper levels of retinoic acid, a metabolite of vitamin A that influences numerous biological processes, including embryonic development, cellular differentiation, and immune response. By creating targeted knockouts of the CYP26B1 gene, researchers can analyze cellular behavior in the absence of this enzyme, providing insights into the molecular pathways regulated by retinoic acid and its implications in various diseases.
The primary function of CYP26B1 knockout cell lines is to enable the streamlined investigation of retinoic acid signaling pathways. These cell lines can be used to elucidate the effects of retinoic acid on gene expression, cell proliferation, and differentiation. Moreover, they serve as a valuable asset in drug discovery, allowing for the identification of potential therapeutic agents that may interact with retinoic acid pathways.
From a scientific perspective, the availability of CYP26B1 knockout cell lines significantly enhances research into developmental biology, oncology, and pharmacology. In clinical settings, understanding the role of retinoic acid metabolism can lead to breakthroughs in therapies for conditions such as cancer, birth defects, and autoimmune diseases.
Unlike alternative models, these knockout cell lines offer a precise and robust platform for retinoic acid studies, minimizing variability that may arise from endogenous CYP26B1 expression. Furthermore, their ease of manipulation and reproducibility make them indispensable tools for both basic and translational research.
For researchers and clinicians focused on the dynamic roles of retinoic acid in health and disease, CYP26B1 Gene Knockout Cell Lines represent a significant advancement with great potential for uncovering novel biological insights and therapeutic possibilities. Our company specializes in providing high-quality, meticulously validated cell lines and other biological products, underpinned by years of expertise in genetic engineering and cell biology, ensuring that our customers are equipped with the best resources for their scientific endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.